BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1597 related articles for article (PubMed ID: 9110382)

  • 21. Nonpeptide angiotensin II receptor antagonists: in vivo inhibition of [125I-Sar1,Ile8]angiotensin II binding by losartan, EXP597 and L-159,282 in rats.
    Wong PC; Herblin WF; Barbera FA; Bernard R; Bozarth TA; Watson CA; Gibson RE
    Clin Exp Hypertens; 1996 Feb; 18(2):189-200. PubMed ID: 8869000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of brain angiotensin in thirst and AVP release induced by hemorrhage.
    Phillips MI; Heininger F; Toffolo S
    Regul Pept; 1996 Oct; 66(1-2):3-11. PubMed ID: 8899885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of angiotensin II-induced facilitation of sympathetic neurotransmission in the pithed rat: a comparison between losartan, irbesartan, telmisartan, and captopril.
    Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
    J Hypertens; 2001 Mar; 19(3):465-73. PubMed ID: 11288817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats.
    Makino N; Sugano M; Otsuka S; Hata T
    Hypertension; 1997 Oct; 30(4):796-802. PubMed ID: 9336375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of AT1 and AT2 receptors in the hypertensive Ren-2 gene transgenic rat kidney.
    Zhuo J; Ohishi M; Mendelsohn FA
    Hypertension; 1999 Jan; 33(1 Pt 2):347-53. PubMed ID: 9931128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin II receptor blockade: an innovative approach to cardiovascular pharmacotherapy.
    Eberhardt RT; Kevak RM; Kang PM; Frishman WH
    J Clin Pharmacol; 1993 Nov; 33(11):1023-38. PubMed ID: 8300885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution and function of cardiac angiotensin AT1- and AT2-receptor subtypes in hypertrophied rat hearts.
    Lopez JJ; Lorell BH; Ingelfinger JR; Weinberg EO; Schunkert H; Diamant D; Tang SS
    Am J Physiol; 1994 Aug; 267(2 Pt 2):H844-52. PubMed ID: 8067441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
    Uhlenius N; Vuolteenaho O; Tikkanen I
    J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in renal angiotensin II receptors in spontaneously hypertensive rats by early treatment with the angiotensin-converting enzyme inhibitor captopril.
    Wu JN; Edwards D; Berecek KH
    Hypertension; 1994 Jun; 23(6 Pt 2):819-22. PubMed ID: 8206610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of losartan, an angiotensin II antagonist, on the development of cardiac hypertrophy due to volume overload.
    Ishiye M; Umemura K; Uematsu T; Nakashima M
    Biol Pharm Bull; 1995 May; 18(5):700-4. PubMed ID: 7492986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
    Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC
    Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential regulation of prostaglandin synthesis by angiotensin peptides in porcine aortic smooth muscle cells: subtypes of angiotensin receptors involved.
    Jaiswal N; Tallant EA; Jaiswal RK; Diz DI; Ferrario CM
    J Pharmacol Exp Ther; 1993 May; 265(2):664-73. PubMed ID: 8496814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal effects of angiotensin I-receptor blockade and angiotensin convertase inhibition in man.
    Schmitt F; Natov S; Martinez F; Lacour B; Hannedouche TP
    Clin Sci (Lond); 1996 Mar; 90(3):205-13. PubMed ID: 8777826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AT1 receptor antagonism enhances angiotensin-II-facilitated carrageenan-induced paw edema.
    Raghavendra V; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 2000 Oct; 22(8):633-6. PubMed ID: 11256235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of the angiotensin II AT2-subtype receptors in the blood pressure-lowering effect of losartan in salt-restricted rats.
    Gigante B; Piras O; De Paolis P; Porcellini A; Natale A; Volpe M
    J Hypertens; 1998 Dec; 16(12 Pt 2):2039-43. PubMed ID: 9886894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rabbit renal epithelial angiotensin II receptors.
    Dulin NO; Ernsberger P; Suciu DJ; Douglas JG
    Am J Physiol; 1994 Nov; 267(5 Pt 2):F776-82. PubMed ID: 7977780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential regulation of cardiac angiotensin converting enzyme binding sites and AT1 receptor density in the failing human heart.
    Zisman LS; Asano K; Dutcher DL; Ferdensi A; Robertson AD; Jenkin M; Bush EW; Bohlmeyer T; Perryman MB; Bristow MR
    Circulation; 1998 Oct; 98(17):1735-41. PubMed ID: 9788827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT1-receptor antagonist.
    Lee SH; Jung YS; Lee BH; Yun SI; Yoo SE; Shin HS
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):367-74. PubMed ID: 10069670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems.
    Spinale FG; de Gasparo M; Whitebread S; Hebbar L; Clair MJ; Melton DM; Krombach RS; Mukherjee R; Iannini JP; O SJ
    Circulation; 1997 Oct; 96(7):2385-96. PubMed ID: 9337215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacology of XR510, a potent orally active nonpeptide angiotensin II AT1 receptor antagonist with high affinity for the AT2 receptor subtype.
    Wong PC; Quan ML; Saye JM; Bernard R; Crain EJ; McCall DE; Watson CA; Zaspel AM; Smith RD; Wexler RR
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):354-62. PubMed ID: 8583775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 80.